Antibodies News and Research

RSS

Guiding nanoparticles directly to the tumor cells

Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue. An interdisciplinary team of researchers at Helmholtz-Zentrum Dresden-Rossendorf and FU Berlin has made important progress in this area: the scientists have produced tiny nanoparticles that are designed to specifically target cancer cells.

24 Feb 2020

Scientific breakthrough provides insights into basic mechanisms of allergic reactions

An international research team has been able to describe the overall structure of the antibody type IgE, which is the key molecule in allergic diseases.

24 Feb 2020

Simple blood test could be used by GPs to aid in earlier brain tumor diagnosis

A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.

24 Feb 2020

A step towards precision medicine for the management of monogenic diabetes

Diabetes affects more than 400 million people worldwide and is a major public health problem. Although commonly referred to as a single disease, it actually constitutes a group of metabolic disorders with hyperglycemia as a common feature. Of all its forms, monogenic diabetes - due to a mutation in one of the genes involved in the management of blood sugar levels - affects 1% to 4% of all cases of diabetes.

22 Feb 2020

Isolating Single T-cells of Interest using an Optofluidic Platform

Researchers are in desperate need of single-cell analysis techniques and those that allow the isolation of high-value T-cells for research and development.

From Bruker Cellular Analysis 21 Feb 2020

UAH research could have broad implications for immunotherapy and cancer treatment

Research into engineering artificial organs that mimic the functions of human lymph nodes at The University of Alabama in Huntsville has garnered one of its professors a $507,777 National Science Foundation Faculty Early Career Development Program Award.

21 Feb 2020

Columbia teams receive $2.1 million grant to find potential antiviral drugs for 2019-nCoV

Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus, 2019-nCoV.

20 Feb 2020

MILabs achieves breakthrough in preclinical oncology imaging by eliminating positron range blurring effect

Researchers at MILabs B.V. have succeeded at imaging the popular Zirconium-89 isotope in small animals of human disease at very high resolutions (<0.75 mm).

19 Feb 2020

Exploring how brain inflammation after stroke can be shaped to support recovery

University of Kentucky College of Medicine researcher Ann Stowe describes her career path as nontraditional. After earning a bachelor's degree in fine arts, Stowe decided to pursue graduate study in biomedical research instead of art history.

19 Feb 2020

Vaccine for COVID-19 coronavirus could soon be a reality

A team of researchers from the University of Texas at Austin and the National Institutes of Health have managed to make significant progress in the development of a vaccine against the fast-spreading and virulent COVID-19/Novel coronavirus that started in Wuhan, Hubei province of China in December 2019 and is still infecting thousands.

19 Feb 2020

Study identifies new CoV responsible for the Wuhan outbreak

The 2019 novel coronavirus causes fatal pneumonia that has claimed over 1300 lives, with more than 52000 confirmed cases of infection by February 13, 2020, all in the span of just over a month.

18 Feb 2020

Scientists use toxin from rattlesnake venom for chronic pain

Rattlesnake (Crotalus adamanteus) is the largest venomous snake in North America, reaching 8 feet and weighing up to 10 pounds. In the past, medical experts believe that the toxin in rattlesnake venom, crotoxin, is a promising compound for the treatment of chronic pain.

18 Feb 2020

Plasma from recovered patients used to treat coronavirus a valid approach, WHO says

The COVID-19 (coronavirus disease) outbreak has taken nearly 1,900 people and infected more than 73,000 people, mainly in China. It has spread to 28 countries, prompting scientists to develop potential therapies to treat deadly viral infections. Now, Chinese doctors are using plasma therapy to treat coronavirus patients.

18 Feb 2020

New understanding on how cancer cells communicate

Researchers from University College London have devised a new way by which they could decipher the language cancer cells use to communicate among themselves. They found this unique method of communication between the cancer cells in organoids or collections of cells mimicking a mini organism in the lab.

17 Feb 2020

New technique helps decipher how individual cancer cells communicate with each other

Scientists have a developed a new technique to decipher how millions of individual cells are communicating with each other in miniature tumors grown in the lab, known as organoids, according to new research published in Nature Methods today (Monday).

17 Feb 2020

Immune system may target other remote areas of the brain to improve stroke recovery

New University of Kentucky research shows that the immune system may target other remote areas of the brain to improve recovery after a stroke.

17 Feb 2020

New technology enables scientists to analyze behavior of cancer cells in lab-grown tumors

New technology developed at UCL is, for the first time, enabling cancer scientists to analyze the individual behavior of millions of different cells living inside lab-grown tumors - a breakthrough which could lead to new personalised cancer treatments.

17 Feb 2020

New technique can label diverse molecules in a single tissue sample

A new technique can label diverse molecules and amplify the signal to help researchers spot those that are especially rare. Called SABER (signal amplification by exchange reaction), Peng Yin's lab at Harvard's Wyss Institute first introduced this method last year and since have found ways to apply it to proteins, DNA and RNA.

16 Feb 2020

Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain

Crotoxin, extracted from the venom of the South American rattlesnake Crotalus durissus terrificus, has been studied for almost a century for its analgesic, anti-inflammatory and antitumor activities and as an even more powerful muscle paralyzer than botulinum toxin.

16 Feb 2020

Novel technology could reduce coronavirus diagnostic time to 15 minutes

Diagnosing coronavirus takes approximately one hour using current methods. A new technology, based on a combination of optics and magnetic particles, can rapidly test 100 samples of patients potentially infected with the virus and reduce the diagnostic time to approximately 15 minutes.

16 Feb 2020

Antibodies News and Research

Guiding nanoparticles directly to the tumor cells

Scientific breakthrough provides insights into basic mechanisms of allergic reactions

Simple blood test could be used by GPs to aid in earlier brain tumor diagnosis

A step towards precision medicine for the management of monogenic diabetes

Isolating Single T-cells of Interest using an Optofluidic Platform

UAH research could have broad implications for immunotherapy and cancer treatment

Columbia teams receive $2.1 million grant to find potential antiviral drugs for 2019-nCoV

MILabs achieves breakthrough in preclinical oncology imaging by eliminating positron range blurring effect

Exploring how brain inflammation after stroke can be shaped to support recovery

Vaccine for COVID-19 coronavirus could soon be a reality

Study identifies new CoV responsible for the Wuhan outbreak

Scientists use toxin from rattlesnake venom for chronic pain

Plasma from recovered patients used to treat coronavirus a valid approach, WHO says

New understanding on how cancer cells communicate

New technique helps decipher how individual cancer cells communicate with each other

Immune system may target other remote areas of the brain to improve stroke recovery

New technology enables scientists to analyze behavior of cancer cells in lab-grown tumors

New technique can label diverse molecules in a single tissue sample

Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain

Novel technology could reduce coronavirus diagnostic time to 15 minutes

Immunology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News